Related Experiment Videos
Mitochondrial DNA in focal dystonia: a cybrid analysis
S J Tabrizi1, J M Cooper, A H Schapira
1University Department of Clinical Neurosciences, Royal Free Hospital School of Medicine, London, UK.
Abstract:
The cause and pathophysiology of dystonia remain unknown. The recent identification of mitochondrial complex I deficiency in platelets from patients with sporadic focal dystonia suggests that a defect of energy metabolism may be relevant in a proportion of patients. We have addressed the possible contribution of mitochondrial DNA (mtDNA) to the complex I deficiency in dystonia by the use of genome transfer technology. Platelets from patients deficient for complex I were fused with A549 p0 (mtDNA-less) cells to form cybrids comprising the A549 nucleus and dystonia mtDNA. Mixed cybrid cell lines were analyzed for 9 controls and 9 dystonia patients, and clonal cybrid lines were generated for 2 control and 2 dystonia patients. Subsequent biochemical analysis showed that the dystonia complex I defect was complemented in both the mixed and the clonal cybrid lines. These results contrast with similar studies in mitochondrial myopathy and Parkinson's disease patients, in which the mitochondrial defect was maintained in at least a proportion of A549 cybrids, and suggest that the complex I defect in dystonia is not caused by an mtDNA mutation.
Insights
Mitochondrial complex I deficiency in dystonia is not caused by mutations in mitochondrial DNA. Genome transfer studies indicate the defect is not inherited via mitochondrial DNA, suggesting nuclear gene involvement.
Area of Science:
- Biochemistry
- Genetics
- Neuroscience
Background:
- The etiology and pathophysiology of dystonia are largely unknown.
- Mitochondrial complex I deficiency identified in sporadic focal dystonia patients suggests potential energy metabolism defects.
- Mitochondrial DNA (mtDNA) mutations are a known cause of various mitochondrial disorders.
Purpose of the Study:
- To investigate the potential contribution of mitochondrial DNA (mtDNA) to complex I deficiency in dystonia.
- To determine if complex I deficiency in dystonia originates from mtDNA mutations using genome transfer technology.
Main Methods:
- Genome transfer technology was employed, fusing platelets from complex I-deficient dystonia patients with mtDNA-less A549 cells to create cybrids.
- Analysis included mixed and clonal cybrid cell lines derived from both control and dystonia patient samples.
- Biochemical assays were performed to assess mitochondrial complex I activity in the generated cybrids.
Main Results:
- The complex I deficiency observed in dystonia patient cells was successfully complemented in both mixed and clonal cybrid cell lines.
- This complementation contrasts with findings in mitochondrial myopathy and Parkinson's disease, where defects were often maintained.
- The results indicate that the complex I defect in dystonia is not attributable to mutations within the mitochondrial DNA.
Conclusions:
- The complex I deficiency in dystonia is unlikely to be caused by mutations in mitochondrial DNA.
- These findings suggest that nuclear gene defects may play a role in the pathophysiology of complex I deficiency in dystonia.
- Further research is warranted to identify the specific genetic factors contributing to this neurological disorder.